Source: International Congress 2014 – Rebuilding: new perspectives on lung bioengineering
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Weiss (Burlington, United States of America). Cell therapy for acute and chronic lung disease. International Congress 2014 – Rebuilding: new perspectives on lung bioengineering

Member's Comments

No comment yet.

Related content which might interest you: Cell therapy for lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Cell therapy for lung disease Source: Eur Respir Rev, 26 (144) 170044; 10.1183/16000617.0044-2017 Year: 2017 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Prediction of chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Acute exacerbations of interstitial lung disease Source: Eur Respir Monogr 2016; 74: 117-131 Year: 2016 Management of acute exacerbation of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387 Year: 2006 Acute and chronic lung infections Source: ERS Course 2015 Year: 2015 Transition from treatment to palliation in chronic lung disease Source: Annual Congress 2006 - PG10 - Preparation and palliation for end-of-life in chronic respiratory disease Year: 2006 Severe fibrotic lung disease – How much therapy is too much therapy? Source: Annual Congress 2008 - Clinical Grand Round - an interactive session Year: 2008 Dissecting chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Clinical features of acute exacerbation in chronic birdfancier‘s lung Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006